Niki BioSolutions, Inc.: 10% owner Sheinerman Kira received 8,000 shares

What happened Sheinerman Kira, a 10% owner, received 8,000 derivative shares (award, transaction code A) at $0.00 on Jul 22, 2026, total reported value $0. The filing classifies the transaction as a grant/award of derivative securities.

Key details

• Transaction date and price: Jul 22, 2026; $0.00 per share; total reported value $0.
• Transaction code: A (grant/award of derivative securities).
• Shares owned after the transaction: not reported in the filing.
• Footnote F1 (vesting): 2,000 options vested immediately upon the closing of the merger; the remaining 6,000 options vest in three equal quarterly installments of 2,000 options each, commencing on the first business day of the first full quarter following the effective date of the merger.
• Filing date: Oct 21, 2026 — the Form 4 was filed after the transaction date.

Why it may matter

• This was an award of derivative securities (options), not an open-market purchase or sale.
• The award vests over time per footnote F1; 2,000 vested immediately and 6,000 vest in three quarterly installments.
• Sheinerman Kira is listed as a 10% owner (a large holder, not an executive).
  This filing does not show why the insider traded or why the company acted.